These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 2502041
1. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes]. Ordosgoitia H, Castro C, Carbayeda M, Labella T. An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041 [Abstract] [Full Text] [Related]
2. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo]. López Martínez R. Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560 [No Abstract] [Full Text] [Related]
3. [The effect of pharmacological treatment in the compensation of vertigo]. Pons Rocher F. An Otorrinolaringol Ibero Am; 1999; 26(3):271-91. PubMed ID: 10394686 [Abstract] [Full Text] [Related]
4. [Clinical and therapeutic experience in 151 consecutive protocolized cases with vertigo syndrome of cervical origin. Comparative study of a cinnarizine and dihydroergocristine combination with a cinnarizine and dihydroergocristine plus anti-inflammatory agents combination]. Bartual J, Vidal J, Magro E, Roquette J. Acta Otorrinolaringol Esp; 1988; 39(5):331-8. PubMed ID: 3152492 [No Abstract] [Full Text] [Related]
5. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. Oosterveld WJ. Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617 [Abstract] [Full Text] [Related]
6. [On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)]. Oswald WD, Matejcek M, Lukaschek K, Dennler HJ, Oswald B. Arzneimittelforschung; 1982; 32(5):584-90. PubMed ID: 7201839 [Abstract] [Full Text] [Related]
10. [On the dose-effect relationship in the therapy with piracetam (author's transl)]. Kretschmar JH, Kretschmar CH. Arzneimittelforschung; 1976; 26(6):1158-9. PubMed ID: 786310 [Abstract] [Full Text] [Related]
11. [Clinical use of piracetam in chronic alcoholism and its complications predelirium and delirium]. Ulbricht B. Med Welt; 1976 Oct 01; 27(40):1912-5. PubMed ID: 790079 [No Abstract] [Full Text] [Related]
13. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease. Smith RC, Vroulis G, Johnson R, Morgan R. Psychopharmacol Bull; 1984 Oct 01; 20(3):542-5. PubMed ID: 6433396 [No Abstract] [Full Text] [Related]
15. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs. Kabes J, Sikora J, Pisvejc J, Hanzlicek L, Skondia V. Int Pharmacopsychiatry; 1982 Oct 01; 17(3):185-92. PubMed ID: 6128331 [Abstract] [Full Text] [Related]
17. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency. Bagadia VN, Gada MT, Mundra VK, Simon S, Doshi JM, Pradhan PV, Shah LP, Sheth UK. J Postgrad Med; 1980 Apr 01; 26(2):116-20. PubMed ID: 7012328 [No Abstract] [Full Text] [Related]
18. [Value of piracetam in the treatment of sudden idiopathic deafness. Preliminary report]. Gersdorff M, Franceschi D. Ann Otolaryngol Chir Cervicofac; 1986 Apr 01; 103(4):283-5. PubMed ID: 3777763 [Abstract] [Full Text] [Related]